|
|
Facult de Pharmacie, 5 rue Jean-Baptiste Clment
Chtenay-Malabry, 92296 France
phone:
fax:
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.immutep.com/
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| LAG-3 protein-based immunotherapeutics to treat cancer and chronic viral infections. |
|
| Management |
| John B. Hawken, President and CEO; Frdric Triebel, Scientific and Medical Director |
| |
|
|
| |
|
| Keywords |
| biopharmaceutical, lag-3, protein, immunotherapeutics, immune, t-cell, cancer, chronic, viral, infections, animal, tumor, hepatites, antigen, vaccine, protein, in vivo |
|
|
|
| Description |
|
Immutep is focused on the development and commercialization of innovative LAG-3 protein-based immunotherapeutics. Immutep's technology will make it possible to carry out therapeutic vaccination to treat those diseases where the only effective immune response has to come from T-cells. These include cancer and chronic viral infections. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members